SCN4A variants and Brugada syndrome: Phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies

European Journal of Human Genetics

Volumn 24, Issue 3, 2016, Pages 400-407

  Bissay, Véronique ^a   Van Malderen, Sophie C H ^a,b   Keymolen, Kathelijn ^a   Lissens, Willy ^a   Peeters, Uschi ^a   Daneels, Dorien ^a   Jansen, Anna C ^a   Pappaert, Gudrun ^a   Rugada, Pedro ^a   De Keyser, Jacques ^a,c   Van Dooren, Sonia ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL NAV1.4; SCN4A PROTEIN, HUMAN;

ADULT; ARTICLE; BRUGADA SYNDROME; CHANNELOPATHY; CLINICAL ARTICLE; DMPK GENE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HEART ARRHYTHMIA; HEART MUSCLE; HUMAN; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SCN4A GENE; SKELETAL MUSCLE; SODIUM CHANNELOPATHY; THOMSEN DISEASE; WORK; AGED; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MUTATION; PATHOLOGY;

ADULT; AGED; BRUGADA SYNDROME; CHANNELOPATHIES; ELECTROCARDIOGRAPHY; ELECTROMYOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUTATION; MYOCARDIUM; NAV1.4 VOLTAGE-GATED SODIUM CHANNEL; PHENOTYPE; ULTRASONOGRAPHY;

EID: 84958107654     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.125     Document Type: Article

References (58)

1. George Jr AL. Inherited disorders of voltage-gated sodium channels. J Clin Invest 2005; 115: 1990-1999
2. Kapplinger JD, Tester DJ, Alders M., et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010; 7: 33-46
3. Nielsen MW, Holst AG, Olesen S-P, Olesen MS. The genetic component of Brugada syndrome. Front Physiol 2013; 4: 179
4. Horga A, Raja Rayan DL, Matthews E., et al. Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology 2013; 80: 1472-1475
5. Péréon Y, Lande G, Demolombe S., et al. Paramyotonia congenita with an SCN4A mutation affecting cardiac repolarization. Neurology 2003; 60: 340-342
6. Maffè S, Signorotti F, Perucca A., et al. Atypical arrhythmic complications in familial hypokalemic periodic paralysis. J Cardiovasc Med (Hagerstown) 2009; 10: 68-71
7. Blechschmidt S, Haufe V, Benndorf K, Zimmer T: Voltage-gated Na+ channel transcript patterns in the mammalian heart are species-dependent. Prog Biophys Mol Biol 2008; 98: 309-318
8. Kaufmann SG, Westenbroek RE, Maass AH., et al. Distribution and function of sodium channel subtypes in human atrial myocardium. J Mol Cell Cardiol 2013; 61: 133-141
9. Hofman N, Tan HL, AldersMet al. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience. Circulation 2013; 128: 1513-1521
10. Wallis Y, Payne S, McAnulty C., et al. Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Medicine. Guidelines updated by the Association for Clinical Genetic Science (ACGS) and the Dutch Society of Clinical Genetical Laboratory Specialists (VKGL) (approved September 2013). Universitair Medisch Centrum: St Radboud
11. Fournier E, Arzel M, Sternberg D., et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 2004; 56: 650-661
12. Fournier E, Viala K, Gervais H., et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 2006; 60: 356-365
13. Matthews E, Tan SV, Fialho D., et al. What causes paramyotonia in the United Kingdom?. Common and new SCN4A mutations revealed. Neurology 2008; 70: 50-53
14. Bissay V, Keymolen K, Lissens W, Laureys G, Schmedding E, De Keyser J: Late onset painful cold-Aggravated myotonia: three families with SCN4A L1436P mutation. Neuromuscul Disord 2011; 21: 590-593
15. Shinlapawittayatorn K, Du XX, Liu H, Ficker E, Kaufman ES, Deschênes I: A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm 2011; 8: 455-462
16. Gouas L, Nicaud V, Berthet M., et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet 2005; 13: 1213-1222
17. Kim DS, Kim EJ, Jung DS., et al. A Korean family with Arg1448Cys mutation of SCN4A channel causing paramyotonia congenita: electrophysiologic, histopathologic, and molecular genetic studies. J Korean Med Sci 2002; 17: 856-860
18. Bissay V, Keymolen K, Lissens W, Schmedding E, De Keyser J: A novel mutation in the SCN4A responsible for cold-induced myotonia with normal electromyography findings on room temperature. J Neurol Sci 2011; 308: 162-164
19. Priori SG, Wilde AA, Horie M., et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013; 15: 1389-1406
20. Rolf S, Bruns HJ, Wichter T., et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J 2003; 24: 1104-1112
21. Ackerman MJ, Marcou CA, Tester DJ. Personalized medicine: genetic diagnosis for inherited cardiomyopathies/channelopathies. Rev Esp Cardiol 2013; 66: 298-307
22. Li H, Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760
23. Picard-tools - A set of tools for working with next generation data in the BAM format. Available at. http://broadinstitute.github.io/picard (version 1.97) (last accessed 26 August 2013
24. Li H, Handsaker B, Wysoker A., et al. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25: 2078-2079
25. McKenna A, Hanna M, Banks E., et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297-1303
26. Antzelevitch C, Brugada P, Borggrefe M., et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005; 2: 429-440
27. Trip J, Drost G, Verbove DJ., et al. In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia. Eur J Hum Genet 2008; 16: 921-929
28. Brook JD, McCurrach ME, Harley HG., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992; 68: 799-808
29. Warner JP, Barron LH, Goudie D., et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 1996; 33: 1022-1026
30. Junttila MJ, Raatikainen MJ, Karjalainen J, Kauma H, Kesäniemi YA, Huikuri HV. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-Aged Finnish population. Eur Heart J 2004; 25: 874-878
31. Gui J, Wang T, Jones RP, Trump D, Zimmer T, Lei M: Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome. PLoS One 2010; 5: e10985
32. Zhang Y, Wang T, Ma A., et al. Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel. Acta Physiol (Oxf) 2008; 194: 311-323
33. Baquero JL, Ayala RA, Wang J., et al. Hyperkalemic periodic paralysis with cardiac dysrhythmia: a novel sodium channel mutation?. Ann Neurol 1995; 37: 408-411
34. Xiuhai G, Weiping W, Ke Z, Hongbin W, Yiling S, Yanling M: Mutations of sodium channel alpha-subunit genes in Chinese patients with normokalemic periodic paralysis. Cell Mol Neurobiol 2008; 28: 653-661
35. Green DS, Hayward LJ, George Jr AL, Cannon SC: A proposed mutation, Val781Ile, associated with hyperkalemic periodic paralysis and cardiac dysrhythmia is a benign polymorphism. Ann Neurol 1997; 42: 253-256
36. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol 2003; 4: 207
37. Anyukhovsky EP, Sosunov EA, Kryukova YN., et al. Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart. Cardiovasc Res 2011; 89: 41-50
38. Wilde AA, Postema PG, Di Diego JM., et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol 2010; 49: 543-553
39. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 2005; 67: 367-378
40. Wilde AA, Brugada R: Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res 2011; 108: 884-897
41. Remme CA, Wilde AA, Bezzina CR. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med 2008; 18: 78-87
42. Rosenfeld J, Sloan-Brown K, George Jr AL: A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 1997; 42: 811-814
43. Alfonsi E, Merlo IM, Tonini M., et al. Efficacy of propafenone in paramyotonia congenita. Neurology 2007; 68: 1080-1081
44. Statland JM, Bundy BN, Wang Y., et al. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA 2012; 308: 1357-1365
45. Moreau A, Keller DI, Huang H., et al. Mexiletine differentially restores the trafficking defects caused by two Brugada syndrome mutations. Front Pharmacol 2012; 3: 62
46. Márquez MF, Salica G, Hermosillo AG., et al. Ionic basis of pharmacological therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2007; 18: 234-240
47. Duan D: Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart. J Physiol 2009; 587: 2163-2177
48. Chen TT, Klassen TL, Goldman AM, Marini C, Guerrini R, Noebels JL. Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy. Neurology 2013; 80: 1078-1085
49. Wahbi K, Algalarrondo V, Bécane HM., et al. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1. Arch Cardiovasc Dis 2013; 106: 635-643
50. Pambrun T, Bortone A, Bois P., et al. Unmasked Brugada pattern by ajmaline challenge in patients with myotonic dystrophy type 1. Ann Noninvasive Electrocardiol 2015; 20: 28-36
51. Coronel R, Casini S, Koopmann TT., et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005; 112: 2769-2777
52. Vignaux O, Lazarus A, Varin J., et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results. Radiology 2002; 224: 231-235
53. Probst V, Wilde AA, Barc J., et al. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2009; 2: 552-557
54. Bezzina CR, Barc J, Mizusawa Y., et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013; 45: 1044-1049
55. Bezzina CR, Rook MB, Groenewegen WA., et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003; 92: 159-168
56. Webster AL, Yan MS, Marsden PA. Epigenetics and cardiovascular disease. Can J Cardiol 2013; 29: 46-57
57. Liu M, Yang KC, Dudley Jr SC. Cardiac sodium channel mutations: why so many phenotypes?. Nat Rev Cardiol 2014; 11: 607-615
58. Robyns T, Nuyens D, Van Casteren L., et al. Reduced penetrance and variable expression of SCN5A mutations and the importance of co-inherited genetic variants: case report and review of the literature. Indian Pacing Electrophysiol J 2014; 14: 133-149